AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,000 | +100.0% | 551 | +64.0% | 0.00% | – |
| Q2 2020 | $5,000 | -54.5% | 336 | -56.3% | 0.00% | – |
| Q1 2020 | $11,000 | -97.4% | 769 | -97.2% | 0.00% | – |
| Q3 2019 | $419,000 | +8280.0% | 27,244 | +13522.0% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -94.7% | 200 | -93.8% | 0.00% | – |
| Q3 2018 | $113,000 | +2160.0% | 3,221 | +1370.8% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 219 | +9.5% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 200 | -23.7% | 0.00% | – |
| Q4 2017 | $4,000 | -50.0% | 262 | -10.6% | 0.00% | – |
| Q3 2017 | $8,000 | – | 293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |